U.S. Physical Therapy, Inc. (USPH) Stock
USPH Key Statistics
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.
CEO: Christopher J. Reading. Company website
USPH — Frequently Asked Questions
What is the USPH stock price today?
U.S. Physical Therapy, Inc. (USPH) trades at $82.47, down 0.73% on the day, as of Sep 20, 2026 14:59 UTC.
What is U.S. Physical Therapy, Inc.'s market cap?
U.S. Physical Therapy, Inc. has a market capitalisation of $1.26B, calculated from the live USPH share price and shares outstanding.
What is the P/E ratio of USPH?
USPH trades at a trailing P/E of 485.12, from earnings per share of $0.17 over the last twelve months.
How much revenue does U.S. Physical Therapy, Inc. make?
U.S. Physical Therapy, Inc. generated revenue of $779.10M over the trailing twelve months, which puts the stock at 1.61 times sales.
What is the 52-week range for USPH?
USPH has traded between $58.19 and $93.50 over the past 52 weeks, and the last price is 11.8% below that high.
Is U.S. Physical Therapy, Inc. profitable?
No. U.S. Physical Therapy, Inc. is loss-making, with a net margin of -0.77% over the trailing twelve months.
What is the analyst price target for USPH?
Wall Street analysts rate USPH Buy, with an average price target of $90.00, 9.1% above the current price.
What sector is U.S. Physical Therapy, Inc. in?
U.S. Physical Therapy, Inc. is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in US.
Who is the CEO of U.S. Physical Therapy, Inc.?
Christopher J. Reading is the chief executive of U.S. Physical Therapy, Inc., which employs 6,374 people.
Where can I track USPH in real time?
QFI Terminal shows USPH with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See USPH live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open USPH in Terminal See plans